COVID-19 update

Octapharma is at the forefront of the fight against COVID-19, applying our expertise in immunoglobulins to investigate potential COVID-19 treatments.

Learn more about our COVID-19 response

News & stories

Check out our latest stories

Octapharma statement on social justice

FDA approves Octapharma USA investigational new drug application for severe COVID-19 patients

Octapharma acts to accelerate development of COVID-19 plasma therapies

Octapharma USA extends funding for COVID-19 study

Study in California utilizing IVIG as investigational coronavirus treatment for adults experiencing respirator

Patient engagement

Octapharma takes an active role in our community

We sponsor and support organizations worldwide.

Learn how we engage with patients

Our products

Products

Learn more about our products to treat rare diseases and other coagulopathies and bleeding disorders.